SCHEMBL6509929

SCHEMBL6509929

CC(C)(C)OC(=O)NC(C)(C=O)c1cccc(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 4/20 0.42
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
RXFP1 Q9HBX9 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
HTT P42858 1/20 0.37
TSHR P16473 2/20 0.36
LMNA P02545 1/20 0.36
PPARG P37231 1/20 0.36
NCOA2 Q15596 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
MTOR P42345 1/20 0.36
MAPK10 P53779 1/20 0.36
EDNRB P24530 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6343801 0.85 AAK1 (0.36) CTSSCTSKRXFP1NPC1RAB9A
SCHEMBL5969759 0.84 HDAC3 (0.46) KCNN4CTSSCTSKRXFP1HDAC3
SCHEMBL244304 0.83 AAK1 (0.43) CTSSCTSKRXFP1NPC1RAB9A
SCHEMBL15124834 0.83 AAK1 (0.43) CTSSCTSKRXFP1NPC1RAB9A
SCHEMBL244443 0.79 MAPT (0.56) NPC1RAB9AHTTLMNAALDH1A1
SCHEMBL3710918 0.77 CTSS (0.41) KCNN4CTSSCTSKRXFP1HDAC3
SCHEMBL5634375 0.77 CTSS (0.43) KCNN4CTSSCTSKRXFP1HDAC3
SCHEMBL29548044 0.76 GUCY1B2 (0.41) KCNN4CTSSCTSKRXFP1HDAC3
SCHEMBL18033976 0.76 GUCY1B2 (0.41) KCNN4CTSSCTSKRXFP1HDAC3
SCHEMBL14847820 0.75 GAA (0.45) NPC1RAB9APPARGALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124683-A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis AGOURON PHARMACEUTICALS, INC. 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124683-A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis PEPD, SERPINB1, ACE KCNN4 4860/4885CTSS 12/4885CTSK 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.